Skip to main content
. 2022 Jul 19;15:1533–1545. doi: 10.2147/JMDH.S367607

Table 3.

Management Goals

PCP (n = 318) Hepatology (n = 57) Gastroenterology (n = 156) Endocrinology (n = 98)
Management goal for patient with confirmed NASH via liver biopsy*
Weight loss 1.9 1.7 1.5 1.6
Improved control of diabetes 2.3 2.4 2.2 2.3
Improved lipid profile 3.3 3.4 3.3 3.5
NASH downstaging or regression in liver fibrosis 3.4 3.0 3.3 3.0
Symptom improvement 4.1 4.5 4.7 4.5
Weight loss of what percent body weight is your goal for this patient as a component of NASH management?
Less than 5% 0% 0% 0% 0%
5% to 10% 48% 72% 51% 60%
11% to 20% 35% 21% 41% 30%
21% to 30% 11% 7% 5% 4%
No weight loss goal at this time 3% 0% 1% 4%
Other 1% 0% 1% 1%
Unsure 3% 0% 1% 1%
What would your hemoglobin A1c goal be for management of this patient’s NASH?
Less than 6.5% 42% 53% 67% 40%
6.5% to 7.4% 53% 39% 29% 52%
7.5% to 8.4% 2% 4% 2% 4%
8.5% or greater 0% 0% 0% 0%
No A1c goal at this time 1% 2% 0% 0%
Other 1% 4% 1% 3%
Unsure 1% 0% 1% 1%

Notes: *Choices were ranked 1 through 5, where 1 is the most important and 5 is the least important goal. Mean responses shown.